These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6243256)
1. Prostaglandin E2 rather than lymphocyte-activating factor produced by activated human mononuclear cells stimulates increases in murine thymocyte cAMP. Oppenheim JJ; Koopman WJ; Wahl LM; Dougherty SF Cell Immunol; 1980 Jan; 49(1):64-73. PubMed ID: 6243256 [No Abstract] [Full Text] [Related]
2. Mechanisms of action of "lymphocyte activating factor" (LAF)--II. LAF effect is resistant to elevation of cellular cyclic AMP. Kierszenbaum F; Waksman BH Immunochemistry; 1978 Nov; 15(10-11):807-11. PubMed ID: 218885 [No Abstract] [Full Text] [Related]
3. Regulation of thymocyte proliferative response by macrophage-derived prostaglandin E2 and interleukin 1. Hayari Y; Kukulansky T; Globerson A Eur J Immunol; 1985 Jan; 15(1):43-7. PubMed ID: 2981690 [TBL] [Abstract][Full Text] [Related]
4. Mitogenic activity of Actinomyces viscosus. I. Effects on murine B and T lymphocytes, and partial characterization. Engel D; Clagett J; Page R; Williams B J Immunol; 1977 Apr; 118(4):1466-71. PubMed ID: 66295 [TBL] [Abstract][Full Text] [Related]
6. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness. Boraschi D; Meltzer MS J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563 [No Abstract] [Full Text] [Related]
7. Partial characterization of a prostaglandin-induced suppressor factor. Rogers TJ; Nowowiejski I; Webb DR Cell Immunol; 1980 Mar; 50(1):82-93. PubMed ID: 6967359 [No Abstract] [Full Text] [Related]
8. Interactions between 8-L-arginine vasopressin and prostaglandin E2 in human mononuclear phagocytes. Locher R; Vetter W; Block LH J Clin Invest; 1983 Apr; 71(4):884-91. PubMed ID: 6300191 [TBL] [Abstract][Full Text] [Related]
9. The adenosine 3':5'-cyclic monophosphate response to prostaglandin E2 is altered in U937 cells in association with maturational events induced by activated T lymphocytes and 1,25-dihydroxyvitamin D3. Goldring SR; Amento EP; Roelke MS; Krane SM J Immunol; 1986 May; 136(9):3461-6. PubMed ID: 2420890 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E1 treatment of NZB/W mice. III. Preservation of spleen cell concentrations and mitogen-induced proliferative responses. Krakauer KA; Torrey SB; Zurier RB Clin Immunol Immunopathol; 1978 Nov; 11(3):256-66. PubMed ID: 309371 [No Abstract] [Full Text] [Related]
11. The effects of indomethacin on T lymphocyte stimulation. Kingston AE; Ivanyi J; Kay JE Immunol Lett; 1984; 8(6):301-5. PubMed ID: 6335488 [TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandin on the antigen- and mitogen-driven responses of peripheral blood lymphocytes from patients with adult and juvenile periodontitis. Page RC; Clagett JA; Engel LD; Wilde G; Sims T Clin Immunol Immunopathol; 1978 Sep; 11(1):77-87. PubMed ID: 699390 [No Abstract] [Full Text] [Related]
14. Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines. Stadler BM; Dougherty SF; Farrar JJ; Oppenheim JJ J Immunol; 1981 Nov; 127(5):1936-40. PubMed ID: 6975304 [No Abstract] [Full Text] [Related]
15. One third of murine splenic T cells are cytotoxic precursors induced to grow by leucoagglutinin and TCGF. Larsson EL Scand J Immunol; 1981 May; 15(5):515-9. PubMed ID: 6980449 [No Abstract] [Full Text] [Related]